(445 days)
Not Found
No
The document explicitly states that the device performs no analysis or filtering and sends acquired data to a host application where analysis is performed. It also states that the analysis program on the host is a separate product. There are no mentions of AI, ML, or related concepts.
No
The device is for ECG signal acquisition and transmission to support diagnosis, but it explicitly states it is not intended for monitoring, diagnosis, or analysis of cardiac function. It acts as a data capture and relay device, with analysis performed by separate products.
No
The device description explicitly states: "HD+ is not intended for monitoring of the cardiac function or to diagnose the patient's health condition." and "HD+ is not intended to control or analysis heart function and/or to diagnose the patient's health status." It functions solely as an acquisition and transmission device for ECG signals, with diagnosis occurring on a separate host platform.
No
The device description explicitly states that HD+ is a "digital portable acquisition device" and a "wireless acquisition device," which are hardware components. It acquires and transmits the ECG signal, but the analysis and display are performed on a separate host application.
Based on the provided text, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
- Device Function: The HD+ device acquires and transmits electrical signals from the patient's body (ECG). It does not perform any analysis or testing on biological samples.
- Intended Use: The intended use is to support the diagnosis of patient conditions by providing ECG data. This is a physiological measurement, not an in vitro test.
- Lack of Sample Analysis: The text explicitly states that the device "sends the data to the receiver device without performing any analysis or filtering" and "does not perform analysis on such signal." The analysis is performed on a separate host platform.
Therefore, the HD+ device falls under the category of a medical device that measures physiological parameters, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The function of the device is the acquisition and transmission of the ECG signal in order to support diagnosis of the patient's conditions.
HD+ is a wireless or USB (with appropriate option) ECG acquisition device, to be used primarily as common front-end for standard PC/tablet platforms (Windows/MAC OS/others), for resting ECG applications.
The device implements wireless communication vireless technology or wired with USB communication. With both connection modes, HD+ sends the data to the receiver device without performing any analysis or filtering. HD+ is not intended for monitoring of the cardiac function or to diagnose the patient's health condition. Display, print and analysis applications on the receiver device are separate products. HD+ is not able to permanently store the acquired data, therefore it does not work unless a connection has been established with a receiver application. Furthermore, HD+ does not collect any of the patient's name, age, previous health conditions etc.).
HD+ detects the QRS complexes and transmit the receiving device. The QRS detection function is intended for patients aged 12 years or older.
*HD+ is indicated for the acquisition of ECG signals with the patient in resting conditions, for example for diagnostic ECG's and rhythm strips
*HD+ is suitable for working at high altitudes, with restrictions.
*HD+ is intended for use on patients, with no limits of age or gender, except for the HR detector function which is intended for patients 12 years or older
- HD+ is intended for use in medical facilities (hospitals, clinics), at home or emergency settings (ambulances).
*HD+ is intended for use by a physician, nurse or other healthcare professional (e.g., ECG technician) who acts following orders by a physician or authorized nurse, including when operated in home environments
*HD+ is not intended for real-time monitoring of vital physiological parameters.
Product codes (comma separated list FDA assigned to the subject device)
DRG
Device Description
HD+12 and HD+15 are the new revisions of Cardioline's HD+ wireless acquisition module. The HD+ is a digital portable acquisition device which can acquire the electrocardiographic signal of 12 and 15 standard leads. Connected with a receiver via Bluetooth or USB (with the optional USB connector), the HD+ performs no analysis or filtering but sends acquired data to a host application where the User Interface is implemented. By default, the device includes a demo compatible software "HD+ Display" whose purpose is providing a UI for viewing the traces acquired by HD+. HD+ Display provides a simple UI, sufficient to configure the application to connect to an HD+ device via Bluetooth (the application automatically detects if an HD+ device is connected via USB and does not require additional configuration) and sufficient to display the ECG traces as received by HD+. HD+ Display does not provide any clinical functionality; therefore, it does not provide any capability to store, print or analyze the acquired ECG.
It is the host (PC or Tablet separated by HD+) which performs the analysis. HD+ is not intended to control or analysis heart function and/or to diagnose the patient's health status. The analysis program on the host is a separate product not marketed with the HD+.
HD+ is a wireless acquisition device, to be primarily used as ECG front-end acquisition device for PC/tablet (Windows/MAC OS/Android/iOS/others) standard platforms for Resting ECG applications. Depending on performance/price ratio, HD+ could be also used with selected embedded electrocardiographs. HD+ allows the patient to be ambulatory.
HD+ uses a standard Bluetooth data transmission technology to transmit 12-lead and 15-lead ECG data over a proximity range, providing electrical insulation and freedom of movement for the patient. The device implements the wireless communication via Bluetooth wireless technology. The Bluetooth radio protocol is implemented by a dedicated module, FCC compliant. In order to support the data transmission speed of the application, the device implements the BLE 5 protocol with DLE (Data Length Extension) and 2M PHY (bandwidth up to 2 Mbit/s). The minimum specifications of the device connected to HD+ is BLE 4.2 to support the band required by acquisitions at 500 s/s. In order to operate at 1000 s/s, the connected device must be BLE 5.0 (or higher) and have a compatible 2M PHY radio (2 Mbit/s). Alternatively, in addition to Bluetooth connectivity described above, the HD+ has an optional USB interface that can be used to transmit data. The USB interface provides an electrical insulation offering two means of patient protection (2MPP), allowing HD+ to be connected to any IT equipment conforming to IEC 62368-1.
The HD+ function consists of acquiring and transmitting ECG signals for display processing ECG signals for the purpose of supporting the diagnosis of patient conditions. The device does not store nor does it associate patient identification data to the acquired signal, nor does it perform analysis on such signal. The HD+ is used solely for transmission of ECG signals from patient to a host analysis platform.
The HD+ transmits a continuous stream of ECG samples at a rate of 500 s/s or 1000 s/s, with a resolution of 0.817 uV/LSB or 2.495 uV/LSB, selectable by the calling application of the host analysis platform. The average required transmission throughput for sending 15 leads at 1000 s/s is approximately 155kbit/s, while to send 12 leads at 500 s/s the required throughput is approximately 54 kbit/s. BLE 5 2M PHY provides the bandwidth needed to support the maximum required throughput.
The BLE communication link ensures that data is either received correctly or not received at all. It is up to the host application to detect packet losses, handling the data gaps appropriately (e.g. by filling the stream with invalid dummy samples, signaling transmission errors etc...). This approach has been preferred over enabling the data retransmission (supported by the module) to reduce the data iitter and transmission delay.
HD+ uses standard 12 lead or 15 lead ECG cables to acquire the physiological signal from the patient. HD+ is light and compact, comfortable to wear, minimizing motion artifacts caused by traditional electrodes and patient cables.
HD+ offers full ECG acquisition - meeting the standards used in clinical and diagnostic applications (AAMI, ANSI, AHA, ACC). HD+ uses a LED indicator to comfortably monitor the link status (off when unit is powered down, blinking when unit is attempting to connect with the receiver, steady when unit is connected with the receiver). HD+ uses a programmable key to send macro commands to the receiving system (i.e. acquire and print an ECG). Low-power technology allows continuous usage of the device for more than 10 hours (from full battery charge).
The HD+ continuously transmits the acquired data to a computer platform where compatible software, a Host Application authorized by Cardioline, is installed that acts as its User Interface. As an example of such Host Application, the device includes a compatible demo Windows application "HD+ display" from Cardioline to visualize the ECG traces and check the functionality of the results of the analysis must always be validated by qualified, trained medical personnel and the HD+ is intended for use in a medical environment. HD+ is intended to be used on adult and all pediatric patients. The device must be handled with care by taking all the necessary precautions in order to prevent and avoid shocks, vibrations, heat sources, liquids and anything else that may damage it.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult and all pediatric patients.
The QRS detection function is intended for patients aged 12 years or older.
Intended User / Care Setting
HD+ is intended for use by a physician, nurse or other healthcare professional (e.g., ECG technician) who acts following orders by a physician or authorized nurse, including when operated in home environments.
HD+ is intended for use in medical facilities (hospitals, clinics), at home or emergency settings (ambulances).
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The following performance data were provided in support of the substantial equivalence determination.
Full safety test according to IEC 60601-1-11, and IEC 60601-2-25 have been performed on the device. These tests have shown full compliance with these standards.
The device has been subjected to Electromagnetic Compatibility testing procedure according to EN 60601-1-2 standard. Tests have shown full compliance with this standard.
The Bluetooth module complies with ETSI EN 300 328, ETSI EN 301 489-1 and ETSI EN 301 489-17 standards concerning the radio equipment and telecommunication terminal equipment. Tests are also carried out according to FCC CFR 47 Part 15 rules. Tests have shown full compliance with these standards.
The performance tests are carried out according to IEC 60601-2-25 and the performance tested are:
- Patient Derivation Polarity
- Minimum System Switch Leads
- Goldberger and Wilson Derivations
- Input Impedance and Circuit Lead
- Common Mode Rejection
- Noise Level
- Writing Speed and Trace Width
- Channels Interaction
- High Frequency Response
- Low Frequency Response
- Linearity and Dynamic Range
- Minimal Signal Response
- Sampling and Resolution
- Recording Speed
- ECG Distortion
- Impulse Visibility of Pace-Maker
- Internal Electrical Source Requirements
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2910 Radiofrequency physiological signal transmitter and receiver.
(a)
Identification. A radiofrequency physiological signal transmitter and receiver is a device used to condition a physiological signal so that it can be transmitted via radiofrequency from one location to another, e.g., a central monitoring station. The received signal is reconditioned by the device into its original format so that it can be displayed.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters 'FDA' in a blue square, followed by the words 'U.S. FOOD & DRUG ADMINISTRATION' in blue text.
May 15, 2023
Cardioline S.P.A % Brian Brenegan Regulatory Correspondent CYA Medical Device Consulting, LLC 34340 Venice Beach Road Oconomowoc, Wisconsin 53066
Re: K220526
Trade/Device Name: HD+12, HD+15 Regulation Number: 21 CFR 870.2910 Regulation Name: Radiofrequency physiological signal transmitter and receiver Regulatory Class: Class II Product Code: DRG Dated: April 14, 2023 Received: April 14, 2023
Dear Brian Brenegan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Aneesh S. Deoras -S
for
Jennifer Shih Kozen Assistant Director Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K220526
Device Name HD+12, HD+15
Indications for Use (Describe)
The function of the device is the acquisition and transmission of the ECG signal in order to support diagnosis of the patient's conditions.
HD+ is a wireless or USB (with appropriate option) ECG acquisition device, to be used primarily as common front-end for standard PC/tablet platforms (Windows/MAC OS/others), for resting ECG applications.
The device implements wireless communication vireless technology or wired with USB communication. With both connection modes, HD+ sends the data to the receiver device without performing any analysis or filtering. HD+ is not intended for monitoring of the cardiac function or to diagnose the patient's health condition. Display, print and analysis applications on the receiver device are separate products. HD+ is not able to permanently store the acquired data, therefore it does not work unless a connection has been established with a receiver application. Furthermore, HD+ does not collect any of the patient's name, age, previous health conditions etc.).
HD+ detects the QRS complexes and transmit the receiving device. The QRS detection function is intended for patients aged 12 years or older.
*HD+ is indicated for the acquisition of ECG signals with the patient in resting conditions, for example for diagnostic ECG's and rhythm strips
*HD+ is suitable for working at high altitudes, with restrictions.
*HD+ is intended for use on patients, with no limits of age or gender, except for the HR detector function which is intended for patients 12 years or older
- HD+ is intended for use in medical facilities (hospitals, clinics), at home or emergency settings (ambulances).
*HD+ is intended for use by a physician, nurse or other healthcare professional (e.g., ECG technician) who acts following orders by a physician or authorized nurse, including when operated in home environments
*HD+ is not intended for real-time monitoring of vital physiological parameters.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
3
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(k) SUMMARY HD+12, HD+15
1. SUBMITTER
CARDIOLINE S.p.A Via Linz, 151 3838121 Trento Italy T +39 0461 96821
Contact Person: David Lombardi Date prepared: 05 May 2023
2. DEVICE
Name of Device: Cardioline HD+12, HD+15 Common or Usual Name: HD+ Classification Name: Physiological Signal Acquisition Device Regulatory Class: II Product Code: DRG CFR 870.2910 Transmitter and Receivers, Physiological Signal, Radiofrequency
3. PREDICATE DEVICE
| Manufacturer name | Applicant Name | Predicate Device | 510(k) Number |
|---|---|---|---|
| Cardioline S.p.A. | Cardioline S.p.A. | HD+ | K150289 |
4. DEVICE DESCRIPTION
HD+12 and HD+15 are the new revisions of Cardioline's HD+ wireless acquisition module. The HD+ is a digital portable acquisition device which can acquire the electrocardiographic signal of 12 and 15 standard leads. Connected with a receiver via Bluetooth or USB (with the optional USB connector), the HD+ performs no analysis or filtering but sends acquired data to a host application where the User Interface is implemented. By default, the device includes a demo compatible software "HD+ Display" whose purpose is providing a UI for viewing the traces acquired by HD+. HD+ Display provides a simple UI, sufficient to configure the application to connect to an HD+ device via Bluetooth (the application automatically detects if an HD+ device is connected via USB and does not require additional configuration) and sufficient to display the ECG traces as received by HD+. HD+ Display does not provide any clinical functionality; therefore, it does not provide any capability to store, print or analyze the acquired ECG.
lt is the host (PC or Tablet separated by HD+) which performs the analysis. HD+ is not intended to control or analysis heart function and/or to diagnose the patient's health status. The analysis program on the host is a separate product not marketed with the HD+.
HD+ is a wireless acquisition device, to be primarily used as ECG front-end acquisition device for PC/tablet (Windows/MAC OS/Android/iOS/others) standard platforms for Resting ECG applications. Depending on performance/price ratio, HD+ could be also used with selected embedded electrocardiographs. HD+ allows the patient to be ambulatory.
5
HD+ uses a standard Bluetooth data transmission technology to transmit 12-lead and 15-lead ECG data over a proximity range, providing electrical insulation and freedom of movement for the patient. The device implements the wireless communication via Bluetooth wireless technology. The Bluetooth radio protocol is implemented by a dedicated module, FCC compliant. In order to support the data transmission speed of the application, the device implements the BLE 5 protocol with DLE (Data Length Extension) and 2M PHY (bandwidth up to 2 Mbit/s). The minimum specifications of the device connected to HD+ is BLE 4.2 to support the band required by acquisitions at 500 s/s. In order to operate at 1000 s/s, the connected device must be BLE 5.0 (or higher) and have a compatible 2M PHY radio (2 Mbit/s). Alternatively, in addition to Bluetooth connectivity described above, the HD+ has an optional USB interface that can be used to transmit data. The USB interface provides an electrical insulation offering two means of patient protection (2MPP), allowing HD+ to be connected to any IT equipment conforming to IEC 62368-1.
The HD+ function consists of acquiring and transmitting ECG signals for display processing ECG signals for the purpose of supporting the diagnosis of patient conditions. The device does not store nor does it associate patient identification data to the acquired signal, nor does it perform analysis on such signal. The HD+ is used solely for transmission of ECG signals from patient to a host analysis platform.
The HD+ transmits a continuous stream of ECG samples at a rate of 500 s/s or 1000 s/s, with a resolution of 0.817 uV/LSB or 2.495 uV/LSB, selectable by the calling application of the host analysis platform. The average required transmission throughput for sending 15 leads at 1000 s/s is approximately 155kbit/s, while to send 12 leads at 500 s/s the required throughput is approximately 54 kbit/s. BLE 5 2M PHY provides the bandwidth needed to support the maximum required throughput.
The BLE communication link ensures that data is either received correctly or not received at all. It is up to the host application to detect packet losses, handling the data gaps appropriately (e.g. by filling the stream with invalid dummy samples, signaling transmission errors etc...). This approach has been preferred over enabling the data retransmission (supported by the module) to reduce the data iitter and transmission delay.
HD+ uses standard 12 lead or 15 lead ECG cables to acquire the physiological signal from the patient. HD+ is light and compact, comfortable to wear, minimizing motion artifacts caused by traditional electrodes and patient cables.
HD+ offers full ECG acquisition - meeting the standards used in clinical and diagnostic applications (AAMI, ANSI, AHA, ACC). HD+ uses a LED indicator to comfortably monitor the link status (off when unit is powered down, blinking when unit is attempting to connect with the receiver, steady when unit is connected with the receiver). HD+ uses a programmable key to send macro commands to the receiving system (i.e. acquire and print an ECG). Low-power technology allows continuous usage of the device for more than 10 hours (from full battery charge).
The HD+ continuously transmits the acquired data to a computer platform where compatible software, a Host Application authorized by Cardioline, is installed that acts as its User Interface. As an example of such Host Application, the device includes a compatible demo Windows application "HD+ display" from Cardioline to visualize the ECG traces and check the functionality of the results of the analysis must always be validated by qualified, trained medical personnel and the HD+ is intended for use in a medical environment. HD+ is intended to be used on adult and all pediatric patients. The device must be handled with care by taking all the necessary precautions in order to prevent and avoid shocks, vibrations, heat sources, liquids and anything else that may damage it.
5. INDICATION FOR USE
The function of the device is the acquisition and transmission of the ECG signal in order to support diagnosis of the patient's conditions.
6
HD+ is a wireless or USB (with appropriate option) ECG acquisition device, to be used primarily as common front-end for standard PC/tablet platforms (Windows/MAC OS/others), for resting ECG applications. The device implements wireless communication via Bluetooth wireless technology or wired with USB communication. With both connection modes, HD+ sends the receiver device without performing any analysis or filtering.
HD+ is not intended for monitoring or analysis of the cardiac function or to diagnose the patient's health condition. Display, print and analysis applications on the receiver device are separate products. HD+ is not able to permanently store the acquired data, therefore it does not work unless a connection has been established with a receiver application. Furthermore, HD+ does not collect any of the patient's sensitive data (patient's name, age, previous health conditions etc.).
HD+ detects the QRS complexes and transmit the receiving device. The QRS detection function is intended for patients aged 12 years or older.
- . HD+ is indicated for the acquisition of ECG signals with the patient in resting conditions, for example for diagnostic ECG's and rhythm strips
- 트 HD+ is suitable for working at high altitudes, with restrictions.
- 트 HD+ is intended for use on patients, with no limits of age or gender, except for the HR detector function which is intended for patients 12 years or older
- . HD+ is intended for use in medical facilities (hospitals, clinics), at home or emergency settings (ambulances).
- HD+ is intended for use by a physician, nurse or other healthcare professional (e.g., ECG technician) who acts following orders by a physician or authorized nurse, including when operated in home environments
- . HD+ is not intended for real-time monitoring of vital physiological parameters.
| FEATURES | CARDIOLINE HD+12, HD+15 | CARDIOLINE HD+ | Comparison |
|---|---|---|---|
| Intended use | The function of the device is the | ||
| acquisition and transmission of the | |||
| ECG signal in order to support | |||
| diagnosis of the patient's | |||
| conditions. | |||
| HD+ is a wireless or USB (with | |||
| appropriate option) ECG acquisition | |||
| device, to be used primarily as | |||
| common front-end for standard | |||
| PC/tablet platforms | |||
| (Windows/MAC OS/others), for | |||
| resting ECG applications. | HD+ is a physiological ECG | ||
| acquisition module. HD+ | |||
| transmits wireless, via Bluetooth | |||
| to a PC or Tablet, the data | |||
| acquired, without making any | |||
| analysis or filtering on the data | |||
| acquired. HD+ acquires 12-lead | |||
| ECG waveforms meeting the | |||
| standards for clinical and | |||
| diagnostic applications (AAMI, | |||
| ANSI, AHA, ACC) and offers full | |||
| ECG acquisition. HD+ is designed | |||
| to acquire and transmit a high- | |||
| quality ECG data allowing the | Similar function of the device | ||
| remains the same, addition of | |||
| use environment s (home and | |||
| ambulance), addition of use by a | |||
| physician, nurse or | |||
| The device implements wireless | |||
| communication via Bluetooth | |||
| wireless technology or wired with | |||
| USB communication. With both | |||
| connection modes, HD+ sends the | |||
| data to the receiver device without | |||
| performing any analysis or filtering. | |||
| HD+ is not intended for monitoring | |||
| or analysis of the cardiac function | |||
| or to diagnose the patient's health | |||
| condition. Display, print and | |||
| analysis applications on the | |||
| receiver device are separate | |||
| products. HD+ is not able to | |||
| permanently store the acquired | |||
| data, therefore it does not work | |||
| unless a connection has been | |||
| established with a receiver | |||
| application. Furthermore, HD+ | |||
| does not collect any of the | |||
| patient's sensitive data (patient's | |||
| name, age, previous health | |||
| conditions etc.). | |||
| HD+ detects the QRS complexes | |||
| and transmit the results to the | |||
| receiving device. The QRS detection | |||
| function is intended for patients | |||
| aged 12 years or older. | patient to be free to moving | ||
| (without cable connected to the | |||
| processing unit). | |||
| The HD+ transmits the acquired | |||
| physiological signals in real-time | |||
| to a computer/device where a | |||
| compatible application is | |||
| installed. All data acquired are | |||
| sent via Bluetooth to a receiver | |||
| that it can be a PC, tablet or | |||
| device capable of receiving BT | |||
| data. The ECG is transmitted | |||
| verbatim to the receiving system, | |||
| without LSB or sampling | |||
| adjustment. It is up to the | |||
| receiving system/application to | |||
| perform the necessary processing | |||
| such as (but not limited to) LSB | |||
| scaling, signal filtering, Resting | |||
| ECG analysis etc... | |||
| The device HD+ is intended to be | |||
| used on adult and on all pediatric | |||
| patients. | |||
| The device is intended for use by | |||
| qualified, trained nurses and | |||
| physicians operating in hospitals, | |||
| clinics and medical practices. | other | ||
| healthcare | |||
| professional | |||
| (e.g., ECG | |||
| technician) | |||
| who acts | |||
| following | |||
| orders by a | |||
| physician or | |||
| authorized | |||
| nurse, | |||
| addition of | |||
| wired | |||
| connection | |||
| option | |||
| HD+ is indicated for the | |||
| acquisition of ECG signals | |||
| with the patient in resting | |||
| conditions, for example for | |||
| diagnostic ECG's and | |||
| rhythm strips | |||
| HD+ is suitable for working | |||
| at high altitudes, with | |||
| restrictions. | |||
| HD+ is intended for use on | |||
| patients, with no limits of | |||
| age or gender, except for | |||
| the HR detector function | |||
| which is intended for | |||
| patients 12 years or older | |||
| HD+ is intended for use in | |||
| medical facilities (hospitals | |||
| clinics), at home or | |||
| emergency settings | |||
| (ambulances). |
HD+ is intended for use by a
physician, nurse or other
healthcare professional
(e.g., ECG technician) who
acts following orders by a
physician or authorized
nurse, including when
operated in home
environments
HD+ is not intended for
real-time monitoring of
vital physiological
parameters. | | |
| Target
population | Adults and pediatric patients | Adults and pediatric patients | Same |
| Safety
standards | IEC 60601-1
IEC 60601-2-25
IEC 60601-1-11 | IEC 60601-1
IEC 60601-2-25
CB scheme | Additional
standard for
home use |
| EMC standards | IEC 60601-1-2 | IEC 60601-1-2 | Same |
| RADIO standards | ETSI EN 300 328
ETSI EN 301 489 -1
ETSI EN 301 489 -17
ETSI EN 300 440 -2
FCC CFR47 Part 15 (US) | ETSI EN 300 328
ETSI EN 301 489 -1
ETSI EN 301 489 -17
ETSI EN 300 440 -2
FCC CFR47 Part 15 (US) | Same |
| ECG Leads | 12 and 15 Leads | 12 Leads | Optional 3
additional
leads |
| Sampling Rate | 500 and 1000
samples/second/channel for
analysis | 1000
samples/second/channel for
analysis | Allows for
downgrading
if the
Bluetooth link
does not
provide
sufficient
bandwidth |
| Leads Connector | Single connector | Single connector | Same |
| Standard Leads
Acquired | 12-leads (I, II, III, aVR-L-F, V1-6)
15-leads (I, II, III, aVR-L-F, V1-6, E1-
2-3) | I, II, III, aVR-L-F, V1-6 | Optional 3
additional
leads |
| A/D Conversion | 24 bit | 24 bit | Same |
| Data Resolution | HiRES mode: